Altered cellular immunity in transgenic mice with T cell-specific expression of human D4-guanine diphosphate-dissociation inhibitor (D4-GDI)

International Immunology

Volumn 20, Issue 10, 2008, Pages 1299-1311

  Kondoh, Kensuke ^a,b   Nakata, Yuji ^a,c   Yamaoka, Takashi ^d   Itakura, Mitsuo ^d   Hayashi, Mutsumi ^a   Yamada, Kohji ^a   Hata, Jun Ichi ^a,e   Yamada, Taketo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF TOKUSHIMA   (Japan)

^e NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Cytoskeletal organization; Cytozoic pathogens; Leukemic cells; Proliferation; Rho

Indexed keywords

BCG VACCINE; CD3 ANTIGEN; CONCANAVALIN A; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; PROTEIN KINASE LCK;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOSKELETON; GENE IDENTIFICATION; GRANULOMA; HUMAN; HUMAN CELL; LEUKEMIA CELL; LISTERIOSIS; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; STRESS FIBER; T LYMPHOCYTE; TRANSGENE; TRANSGENIC MOUSE; WILD TYPE;

ANIMALS; CELL LINE, TUMOR; CYTOSKELETON; DNA; GRANULOMA; GUANINE NUCLEOTIDE DISSOCIATION INHIBITORS; HUMANS; IMMUNITY, CELLULAR; LEUKEMIA; LISTERIA; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; MUTANT PROTEINS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM INFECTIONS; ORGAN SPECIFICITY; POINT MUTATION; RHO GTP-BINDING PROTEINS; T-LYMPHOCYTES; TRANSGENES; TUMOR SUPPRESSOR PROTEINS;

EID: 52949124867     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn084     Document Type: Article

References (42)

1. Ridley, A. J. 2006. Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol. 16:522.
2. Fukushima, S., Yamada, T., Hashiguchi, A., Nakata, Y. and Hata, J. 2000. Augmentation of human leukemia cell invasion by the activation of small GTP-binding protein Rho. Exp. Hematol. 28:391.
3. Takai, Y., Sasaki, T. and Matozaki, T. 2001. Small GTP-binding proteins. Physiol. Rev. 81:153.
4. Narumiya, S. 1996. The small GTPase Rho: Cellular functions and signal transduction. J. Biochem. 120:215.
5. Hall, A. 1998, Rho GTPases and the actin cytoskeleton. Science 279:509.
6. Vojtek, A. B. and Cooper, J. A. 1995. Rho family members: Activators of MAP kinase cascades. Cell 82:527.
7. Van Aelst, L. and D'Souza-Schorey, C. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295.
8. Lelias, J. M., Adra, C. N., Wulf, G. M. et al. 1993. cDNA cloning of a human mRNA preferentially expressed in hematopoietic cells and with homology to a GDP-dissociation inhibitor for the rho GTP-binding proteins. Proc. Natl Acad. Sci. USA 90:1479.
9. Scherle, P., Behrens, T. and Staudt, L. M. 1993. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc. Natl Acad. Sci. USA 90:7568.
10. Adra, C. N., Manor, D., Ko, J. L. et al. 1997. Rho-GDlγ: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl Acad. Sci. USA 94:4279.
11. DerMardirossian, C. and Bokoch, G. M. 2005. GDIs: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15:356.
12. Hart, M. J., Maru, Y., Leonard, D. et al. 1992. A GDP dissociation inhibitor that serves as a GTPase inhibitor for the Ras-like protein CDC42Hs. Science 258:812.
13. Chuang, T H., Xu, X., Knaus, U. G., Hart, M. J. and Bokoch, G. M. 1993. GDP dissociation inhibitor prevents intrinsic and GTPase activating protein-stimulated GTP hydrolysis by the Rac GTP-binding protein. J. Biol. Chem. 268:775.
14. Takahashi, K., Sasaki, T., Mamoto, A. et al. 1997. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/ moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272:23371.
15. Gorvel, J. P., Chang, T.-C., Boretto, J., Azuma, T. and Chavrier, P. 1998. Differential properties of D4/LyGDI versus RhoGDI: Phosphorylation and rho GTPase selectivity. FEBS Lett. 422:263.
16. Kasper, B., Tidow, N., Grothues, D. and Welte, K. 2000. Differential expression and regulation of GTPases (RhoA and Rac2) and GDIs (LyGDI and RhoGDI) in neutrophils from patients with severe congenital neutropenia. Blood 95:2947.
17. Groysman, M., Russek, C. S. and Katzav, S. 2000. Vav, a GDP/GTP nucleotide exchange factor, interacts with GDIs, proteins that inhibit GDP/GTP dissociation. FEBS Lett. 467:75.
18. Groysman, M., Hornstein, I., Alcover, A. and Katzav, S. 2002. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways. J. Biol. Chem. 277:50121.
19. Na, S., Chuang, T. H., Cunningham, A. et al. 1996. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J. Biol. Chem. 271:11209.
20. Krieser, R. J. and Eastman, A. 1999. Cleavage and nuclear translocation of the caspase 3 substrate Rho GDP-dissociation inhibitor, D4-GDI, during apoptosis. Cell Death Differ. 6:412.
21. Nakata, Y., Kondoh, K., Fukushima, S. et al. 2008. Mutated D4-guanine diphosphate-dissociation inhibitor is found in human leukemic cells and promotes leukemic cell invasion. Exp. Hematol. 36:37.
22. Schneider, U., Schwenk, H. U. and Bornkamm, G. 1977. Characterization of EBV-genome negative null and T cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19:521.
23. Morikawa, S., Tatsumi, E., Baba, M., Harada, T. and Yasuhira, K. 1978. Two E-rosette-forming lymphoid cell lines. Int. J. Cancer 21:166.
24. Sambrook, J., Fritsch, E. F. and Maniatis, T. 1989. Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbor Laboratory Press, New York.
25. Ren, X. D., Kiosses, W. B. and Schwartz, M. A. 1999. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO. J. 18:578.
26. Reid, T., Furuyashiki, T., Ishizaki, T. et al. 1996. Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the rho-binding domain. J. Biol. Chem. 271:13556.
27. Lenardo, M. J. 1991. Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis. Nature 353:858.
28. Parish, C. R. 1999. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol. Cell Biol. 77:499.
29. Yin, L., Schwartzberg, P., Scharton-Kersten, T. M., Staudt, L. and Lenardo, M. 1997. Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases. Mol. Immunol. 34:481.
30. Ishizaki, H., Togawa, A., Tanaka-Okamoto, M. et al. 2006. Defective chemokine-directed lymphocyte migration and development in the absence of Rho guanosine diphosphate-dissociation inhibitors alpha and beta. J. Immunol. 177:8512.
31. Gosser, Y. Q., Nomanbhoy, T. K., Aghazadeh, B. et al. 1997. C-terminal binding domain of Rho GDP-dissociation inhibitor directs N-terminal inhibitory peptide to GTPases. Nature 387:814.
32. Biou, V., Gibrat, J. F., Levin, J. M., Robson, B. and Garnier, J. 1988. Secondary structure prediction: Combination of three different methods. Protein Eng. 2:185.
33. Na, S., Chuang, T. H., Cunningham, A. et al. 1996. D4-GDI, a substrate of CPP32, is proteolyzed during Fas-induced apoptosis. J Biol. Chem. 271:11209.
34. Danley, D. E., Chuang, T. H. and Bokoch, G. M. 1996. Defective Rho GTPase regulation by IL-1 beta-converting enzyme-mediated cleavage of D4 GDP dissociation inhibitor. J. Immunol. 157:500.
35. Rickers, A., Brockstedt, E., Mapara, M. Y. et al. 1998. Inhibition of CPP32 blocks surface. IgM-mediated apoptosis and D4-GDI cleavage in human BL60 Burkitt lymphoma cells. Eur. J. Immunol. 28:296.
36. Zhang, Y. and Zhang, B. 2006. D4-GDI, a Rho GTPase regulator, promotes breast cancer cell invasiveness. Cancer Res. 66:5592.
37. Zhang, B., Zhang, Y. and Shacter, E. 2003. Caspase 3-mediated inactivation of rac GTPases promotes drug-induced apoptosis in human lymphoma cells. Mol. Cell Biol. 23:5716.
38. Zhang, B., Zhang, Y. and Shacter, E. 2004. Rac1 inhibits apoptosis in human lymphoma cells by stimulating Bad phosphorylation on Ser-75. Mol. Cell Biol. 24:6205.
39. Zhang, B., Zhang, Y., Dagher, M. C. et al. 2005. Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 65:6054.
40. Kettritz, R., Xu, T. X., Faass, B. et al. 2000. TNF-[alpha]-mediated neutrophil apoptosis involves Ly-GDI, a Rho GTPase regulator. J. Leukoc. Biol. 68:277.
41. Hirao, M., Sato, N., Kondo, T. et al. 1996. Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turn-over and Rho-dependent signaling pathway. J. Cell Biol. 135:37.
42. Li, X., Bu, X., Lu, B., Avraham, H., Flavell, R. A. and Lim, B. 2002. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol. Cell Biol. 22:1158.